Biodesix, Inc. (BDSX)
NASDAQ: BDSX · IEX Real-Time Price · USD
1.250
+0.010 (0.81%)
At close: May 1, 2024, 4:00 PM
1.400
+0.150 (12.00%)
After-hours: May 1, 2024, 7:17 PM EDT
Biodesix Revenue
In the year 2023, Biodesix had annual revenue of $49.09M with 28.46% growth. Revenue in the quarter ending December 31, 2023 was $14.67M with 52.68% year-over-year growth.
Revenue (ttm)
$49.09M
Revenue Growth
+28.46%
P/S Ratio
2.92
Revenue / Employee
$226,207
Employees
217
Market Cap
143.19M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 49.09M | 10.88M | 28.46% |
Dec 31, 2022 | 38.21M | -16.29M | -29.89% |
Dec 31, 2021 | 54.51M | 8.95M | 19.64% |
Dec 31, 2020 | 45.56M | 21.01M | 85.55% |
Dec 31, 2019 | 24.55M | 4.12M | 20.16% |
Dec 31, 2018 | 20.43M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
P3 Health Partners | 1.27B |
High Tide | 497.66M |
Seres Therapeutics | 126.33M |
Electromed | 51.69M |
Augmedix | 44.86M |
ClearPoint Neuro | 23.96M |
Syros Pharmaceuticals | 9.94M |
MSP Recovery | 7.71M |
BDSX News
- 8 days ago - Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 - Business Wire
- 22 days ago - Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting - Business Wire
- 26 days ago - Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement - Business Wire
- 5 weeks ago - Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center - Business Wire
- 2 months ago - Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights - Business Wire
- 2 months ago - Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference - Business Wire
- 2 months ago - Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 - Business Wire
- 6 months ago - Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method - Business Wire